Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Colorectal Neoplasms

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 43 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KINROSS J
    Race-specific differences in mucosal sulfidogenic bacteria modify colon cancer risk.
    Gut. 2017 Mar 20. pii: gutjnl-2017-313989. doi: 10.1136/gutjnl-2017-313989.
    PubMed     Text format    


    February 2017
  2. SIRAJ AK, Masoodi T, Bu R, Pratheeshkumar P, et al
    MED12 is recurrently mutated in Middle Eastern colorectal cancer.
    Gut. 2017 Feb 9. pii: gutjnl-2016-313334. doi: 10.1136/gutjnl-2016-313334.
    PubMed     Text format     Abstract available


  3. YAZICI C, Wolf PG, Kim H, Cross TL, et al
    Race-dependent association of sulfidogenic bacteria with colorectal cancer.
    Gut. 2017 Feb 2. pii: gutjnl-2016-313321. doi: 10.1136/gutjnl-2016-313321.
    PubMed     Text format     Abstract available


    January 2017
  4. TULCHINSKY E
    Colorectal cancer cells use the negative feedback regulators of WNT signalling to activate epithelial-mesenchymal transition pathways.
    Gut. 2017 Jan 12. pii: gutjnl-2016-313185. doi: 10.1136/gutjnl-2016-313185.
    PubMed     Text format    


  5. DE KLERK CM, Gupta S, Dekker E, Essink-Bot ML, et al
    Socioeconomic and ethnic inequities within organised colorectal cancer screening programmes worldwide.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313311. doi: 10.1136/gutjnl-2016-313311.
    PubMed     Text format     Abstract available


    December 2016
  6. PASSAMONTI B, Malaspina M, Fraser CG, Tintori B, et al
    A comparative effectiveness trial of two faecal immunochemical tests for haemoglobin (FIT). Assessment of test performance and adherence in a single round of a population-based screening programme for colorectal cancer.
    Gut. 2016 Dec 14. pii: gutjnl-2016-312716. doi: 10.1136/gutjnl-2016-312716.
    PubMed     Text format     Abstract available


    November 2016
  7. COLUSSI D, Zagari RM, Morini B, Fabbri M, et al
    Prevalence of serrated polyposis syndrome in an FIT-based colorectal cancer screening cohort in Italy.
    Gut. 2016 Nov 15. pii: gutjnl-2016-313063. doi: 10.1136/gutjnl-2016-313063.
    PubMed     Text format    


  8. HUANG Y, Zhou J, Luo S, Wang Y, et al
    Identification of a fluorescent small-molecule enhancer for therapeutic autophagy in colorectal cancer by targeting mitochondrial protein translocase TIM44.
    Gut. 2016 Nov 14. pii: gutjnl-2016-311909. doi: 10.1136/gutjnl-2016-311909.
    PubMed     Text format     Abstract available


  9. RHO JH, Ladd JJ, Li CI, Potter JD, et al
    Protein and glycomic plasma markers for early detection of adenoma and colon cancer.
    Gut. 2016 Nov 7. pii: gutjnl-2016-312794. doi: 10.1136/gutjnl-2016-312794.
    PubMed     Text format     Abstract available


    October 2016
  10. NULSEN B, Lewis B
    Response to: 'Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme' by Hassan et al.
    Gut. 2016 Oct 24. pii: gutjnl-2016-313117. doi: 10.1136/gutjnl-2016-313117.
    PubMed     Text format    


  11. DOWNING A, Morris EJ, Corrigan N, Sebag-Montefiore D, et al
    High hospital research participation and improved colorectal cancer survival outcomes: a population-based study.
    Gut. 2016 Oct 19. pii: gutjnl-2015-311308. doi: 10.1136/gutjnl-2015-311308.
    PubMed     Text format     Abstract available


  12. DOUBENI CA, Corley DA, Quinn VP, Jensen CD, et al
    Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study.
    Gut. 2016 Oct 12. pii: gutjnl-2016-312712. doi: 10.1136/gutjnl-2016-312712.
    PubMed     Text format     Abstract available


    September 2016
  13. BOROVSKI T, Vellinga TT, Laoukili J, Santo EE, et al
    Inhibition of RAF1 kinase activity restores apicobasal polarity and impairs tumour growth in human colorectal cancer.
    Gut. 2016 Sep 26. pii: gutjnl-2016-311547. doi: 10.1136/gutjnl-2016-311547.
    PubMed     Text format     Abstract available


  14. LINDNER AU, Salvucci M, Morgan C, Monsefi N, et al
    BCL-2 system analysis identifies high-risk colorectal cancer patients.
    Gut. 2016 Sep 23. pii: gutjnl-2016-312287. doi: 10.1136/gutjnl-2016-312287.
    PubMed     Text format     Abstract available


    August 2016
  15. GROBBEE EJ, van der Vlugt M, van Vuuren AJ, Stroobants AK, et al
    A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311819. doi: 10.1136/gutjnl-2016-311819.
    PubMed     Text format     Abstract available


  16. HASSAN C, Senore C, Radaelli F, De Pretis G, et al
    Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Gut. 2016 Aug 9. pii: gutjnl-2016-311906. doi: 10.1136/gutjnl-2016-311906.
    PubMed     Text format     Abstract available


    July 2016
  17. GRILLET F, Bayet E, Villeronce O, Zappia L, et al
    Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture.
    Gut. 2016 Jul 25. pii: gutjnl-2016-311447. doi: 10.1136/gutjnl-2016-311447.
    PubMed     Text format     Abstract available


  18. SONG M, Zhang X, Meyerhardt JA, Giovannucci EL, et al
    Marine omega-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis.
    Gut. 2016 Jul 19. pii: gutjnl-2016-311990. doi: 10.1136/gutjnl-2016-311990.
    PubMed     Text format     Abstract available


  19. DE ARCANGELIS A, Hamade H, Alpy F, Normand S, et al
    Hemidesmosome integrity protects the colon against colitis and colorectal cancer.
    Gut. 2016 Jul 1. pii: gutjnl-2015-310847. doi: 10.1136/gutjnl-2015-310847.
    PubMed     Text format     Abstract available


    May 2016
  20. MASUGI Y, Nishihara R, Yang J, Mima K, et al
    Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.
    Gut. 2016 May 5. pii: gutjnl-2016-311421. doi: 10.1136/gutjnl-2016-311421.
    PubMed     Text format     Abstract available


    April 2016
  21. FERRER-MAYORGA G, Gomez-Lopez G, Barbachano A, Fernandez-Barral A, et al
    Vitamin D receptor expression and associated gene signature in tumour stromal fibroblasts predict clinical outcome in colorectal cancer.
    Gut. 2016 Apr 6. pii: gutjnl-2015-310977. doi: 10.1136/gutjnl-2015-310977.
    PubMed     Text format     Abstract available


  22. KAMINSKI MF, Anderson J, Valori R, Kraszewska E, et al
    Leadership training to improve adenoma detection rate in screening colonoscopy: a randomised trial.
    Gut. 2016;65:616-24.
    PubMed     Text format     Abstract available


    March 2016
  23. HAUG U, Grobbee EJ, Lansdorp-Vogelaar I, Spaander MC, et al
    Immunochemical faecal occult blood testing to screen for colorectal cancer: can the screening interval be extended?
    Gut. 2016 Mar 22. pii: gutjnl-2015-310102. doi: 10.1136/gutjnl-2015-310102.
    PubMed     Text format     Abstract available


  24. FLEMER B, Lynch DB, Brown JM, Jeffery IB, et al
    Tumour-associated and non-tumour-associated microbiota in colorectal cancer.
    Gut. 2016 Mar 18. pii: gutjnl-2015-309595. doi: 10.1136/gutjnl-2015-309595.
    PubMed     Text format     Abstract available


  25. BURGESS NG, Pellise M, Nanda KS, Hourigan LF, et al
    Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps.
    Gut. 2016;65:437-46.
    PubMed     Text format     Abstract available


  26. FACCIORUSSO A, Ferrusquia J, Muscatiello N
    Lead time bias in estimating survival outcomes.
    Gut. 2016;65:538-9.
    PubMed     Text format    


    February 2016
  27. MA G, Ge Y, Gu D, Du M, et al
    Functional annotation of colorectal cancer susceptibility loci identifies MLH1 rs1800734 associated with MSI patients.
    Gut. 2016 Feb 24. pii: gutjnl-2016-311543. doi: 10.1136/gutjnl-2016-311543.
    PubMed     Text format    


  28. IJSPEERT JE, Bevan R, Senore C, Kaminski MF, et al
    Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview.
    Gut. 2016 Feb 24. pii: gutjnl-2015-310784. doi: 10.1136/gutjnl-2015-310784.
    PubMed     Text format     Abstract available


  29. ZORZI M, Senore C, Da Re F, Barca A, et al
    Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Gut. 2016 Feb 19. pii: gutjnl-2015-310587. doi: 10.1136/gutjnl-2015-310587.
    PubMed     Text format     Abstract available


  30. SONG M, Nishihara R, Wang M, Chan AT, et al
    Plasma 25-hydroxyvitamin D and colorectal cancer risk according to tumour immunity status.
    Gut. 2016;65:296-304.
    PubMed     Text format     Abstract available


  31. COUGNOUX A, Delmas J, Gibold L, Fais T, et al
    Small-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
    Gut. 2016;65:278-85.
    PubMed     Text format     Abstract available


  32. DORIA-ROSE VP, Levin TR, Palitz A, Conell C, et al
    Ten-year incidence of colorectal cancer following a negative screening sigmoidoscopy: an update from the Colorectal Cancer Prevention (CoCaP) programme.
    Gut. 2016;65:271-7.
    PubMed     Text format     Abstract available


    January 2016
  33. ARNOLD M, Sierra MS, Laversanne M, Soerjomataram I, et al
    Global patterns and trends in colorectal cancer incidence and mortality.
    Gut. 2016 Jan 27. pii: gutjnl-2015-310912. doi: 10.1136/gutjnl-2015-310912.
    PubMed     Text format     Abstract available


    December 2015
  34. AMICARELLA F, Muraro MG, Hirt C, Cremonesi E, et al
    Dual role of tumour-infiltrating T helper 17 cells in human colorectal cancer.
    Gut. 2015 Dec 30. pii: gutjnl-2015-310016. doi: 10.1136/gutjnl-2015-310016.
    PubMed     Text format     Abstract available


  35. HUR K, Toiyama Y, Okugawa Y, Ide S, et al
    Circulating microRNA-203 predicts prognosis and metastasis in human colorectal cancer.
    Gut. 2015 Dec 23. pii: gutjnl-2014-308737. doi: 10.1136/gutjnl-2014-308737.
    PubMed     Text format     Abstract available


  36. MENNONNA D, Maccalli C, Romano MC, Garavaglia C, et al
    T cell neoepitope discovery in colorectal cancer by high throughput profiling of somatic mutations in expressed genes.
    Gut. 2015 Dec 17. pii: gutjnl-2015-309453. doi: 10.1136/gutjnl-2015-309453.
    PubMed     Text format     Abstract available


  37. GLUCK N, Shpak B, Brun R, Rosch T, et al
    A novel prepless X-ray imaging capsule for colon cancer screening.
    Gut. 2015 Dec 1. pii: gutjnl-2015-310893. doi: 10.1136/gutjnl-2015-310893.
    PubMed     Text format    


  38. KORTUM B, Campregher C, Lang M, Khare V, et al
    Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre mice.
    Gut. 2015;64:1905-12.
    PubMed     Text format     Abstract available


    November 2015
  39. IJSPEERT JE, Rana SA, Atkinson NS, van Herwaarden YJ, et al
    Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.
    Gut. 2015 Nov 24. pii: gutjnl-2015-310630. doi: 10.1136/gutjnl-2015-310630.
    PubMed     Text format     Abstract available


    October 2015
  40. CHIU SY, Chuang SL, Chen SL, Yen AM, et al
    Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Gut. 2015 Oct 29. pii: gutjnl-2015-310256. doi: 10.1136/gutjnl-2015-310256.
    PubMed     Text format     Abstract available


  41. VAN HEIJNINGEN EM, Lansdorp-Vogelaar I, Steyerberg EW, Goede SL, et al
    Adherence to surveillance guidelines after removal of colorectal adenomas: a large, community-based study.
    Gut. 2015;64:1584-92.
    PubMed     Text format     Abstract available


  42. KALTENBACH T, Rastogi A, Rouse RV, McQuaid KR, et al
    Real-time optical diagnosis for diminutive colorectal polyps using narrow-band imaging: the VALID randomised clinical trial.
    Gut. 2015;64:1569-77.
    PubMed     Text format     Abstract available


  43. HAANSTRA JF, Al-Toma A, Dekker E, Vanhoutvin SA, et al
    Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy.
    Gut. 2015;64:1578-83.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: